Related Experiment Video
Updated: Sep 21, 2025
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
Microtransplantation for myeloid sarcoma: Two case reports
Xue Zhang1, Shuoting Wang1, Fujue Wang1
1Department of Hematology and Research Laboratory of Hematology, West China Hospital, Sichuan University, #37 Guoxue Alley, Wuhou District, Chengdu 610041, Sichuan, China.
Abstract:
Myeloid sarcoma (MS), is a rare extramedullary tumor with a poor prognosis and high recurrence rate. Microtransplantation is one of the alternative methods of traditional transplantation, which does not rely on HLA complete matching, has low toxicity and may retain part of graft-versus-leukemia (GVL) effect. It has been reported that microtransplantation can significantly improve the survival rate of elderly AML patients. At present, there is no report on the application of micro transplantation in MS. We will report two cases of MS treated by micro transplantation. The disease-free survival was 66 months and 55 months respectively.
